Reposted by Daniel Lewis
New paper in @thelancet.com ft. PLRC member Dr. Megan Fitzgerald (@themegascope.bsky.social):
"In this paper, a group of bioethicists, clinician-scientists and people.. with #LongCovid argue that it is ethically imperative to conduct trials of disease-modifying treatments for LC now." 🧵
thelancet.com
The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments
Almost five years after COVID-19 emerged, multiple scientific uncertainties remain
about why some people experience ongoing symptoms long after being infected with SARS-CoV-2
(Long COVID). The pathoph...